Calidi (CLDI) Biotherapeutics will present data supporting RTNova, the company’s systemic antitumor virotherapy platform, at the International Oncolytic Virotherapy Conference, IOVC, in Rotterdam, Netherlands, October 27-30, 2024, and at Immuno US 2024 in San Diego, October 28-30, 2024. In addition, a poster will be presented at the Society for Immunotherapy of Cancer, SITC, Annual Meeting in Houston, November 6-10, 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDI: